Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Médicréa International    ALMED   FR0004178572

MÉDICRÉA INTERNATIONAL (ALMED)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Medicrea International : Files a Lawsuit against K2M Spine, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 07:41pm CEST

The Medicrea Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered device design and manufacturing with UNiD™ Adaptive Spine Intelligence (“ASI”) technology, announces that on Wednesday, November 8th, 2017, Medicrea USA, Inc., filed a lawsuit in the United States District Court for the Southern District of New York against K2M Spine, Inc. and several other defendants. The case has been assigned to the Honorable Analisa Torres, District Judge.

The lawsuit addresses the unlawful acts that K2M and the other defendants have taken over the course of the past year.

Medicrea has revolutionized spinal surgery through our innovative UNID™ technology, the first and only patient-specific spinal rod approved for use in the United States.

We will aggressively pursue all available legal rights to protect our market-leading business.

About Medicrea (www.Medicrea.com)

Through the lens of predictive medicine, Medicrea leads the design, integrated manufacture, and distribution of 30+ FDA approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. By leveraging its proprietary software analysis tools with big data and machine learning technologies and supported by an expansive collection of clinical and scientific data, Medicrea is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room.

Operating in a $10 billion marketplace, Medicrea is a Small and Medium sized Enterprise (SME) with 175 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants.

For further information, please visit: Medicrea.com.

Connect with Medicrea:

FACEBOOK | INSTAGRAM | TWITTER | WEBSITE | YOUTUBE

Medicrea is listed on

EURONEXT Growth Paris

ISIN: FR 0004178572

Ticker: ALMED

LEI: 969500BR1CPTYMTJBA37


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MÉDICRÉA INTERNATIONAL
07/10MEDICREA : Partners with Leading National Spine Distributor to Launch Australian..
BU
07/10MEDICREA : International Raises €3.1 Million
BU
07/09MEDICREA INTERNATIONAL SA : half-yearly sales release
07/05MEDICREA INTERNATIONAL : Announces Record Sales for the First Half of 2018
BU
05/31MEDICREA INTERNATIONAL : Receives World’s First and Only FDA-Clearance to ..
BU
04/11MEDICREA : to Present Clinical Outcomes at ISASS 2018
BU
04/06MEDICREA : Publishes 2017 Full Year Results and First Quarter 2018 Sales
BU
04/02MEDICREA INTERNATIONAL SA : annual earnings release
03/31MEDICREA INTERNATIONAL : Partners with Key Distributor to Form Joint Venture in ..
AQ
03/29MEDICREA : Partners with Key Distributor to Form Joint Venture in Belgium
BU
More news
Chart MÉDICRÉA INTERNATIONAL
Duration : Period :
Médicréa International Technical Analysis Chart | ALMED | FR0004178572 | 4-Traders
Technical analysis trends MÉDICRÉA INTERNATIONAL
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Managers
NameTitle
Denys Sournac Chairman & Chief Executive Officer
David Ryan Chief Operating Officer
Fabrice Kilfiger CFO & Investor Relations Officer
Thomas Mosnier Chief Scientific Officer
Jean-Philippe Caffiero Director & Deputy Chief Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
MÉDICRÉA INTERNATIONAL-9.33%51
STRYKER CORPORATION13.74%65 138
SMITH & NEPHEW3.57%15 564
WRIGHT MEDICAL GROUP NV14.82%2 700
JAPAN LIFELINE CO., LTD.23.09%2 384
GLAUKOS CORP65.73%1 471